Promore Pharma AB
0
0
+SEK0.00+0% 00:00 Today
Statistics
Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Promore Pharma AB (publ), a biopharmaceutical company, develops peptide-based drug candidates in Sweden and internationally. Its product candidates include PXL01 that is in Phase IIa study for the prevention of post-surgical adhesions and scars, and for the prevention of dermal scars, as well as for tendon repair surgery in the hand; and LL-37, which has completed Phase IIb clinical studies for treating patients with venous leg ulcers, stimulate the healing of chronic wounds, and for the treatment of diabetic foot ulcers. The company was formerly known as Lipopeptide AB and changed its name to Promore Pharma AB (publ) in January 2017. Promore Pharma AB (publ) was founded in 2002 and is headquartered in Solna, Sweden.
Show More
CEO
Dr. Jonas Ekblom Ph.D.
Employees
1
Country
Sweden
ISIN
SE0016074629
Listings
0 Comments
Share your thoughts
FAQs
What is Promore Pharma AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Stockholm Exchange exchange Promore Pharma AB stocks are traded under the ticker PROMO-BTA.ST.
How many employees does Promore Pharma AB have?▼
As of November 3, 2026, the company has 1 employees.
In which sector is Promore Pharma AB located?▼
Promore Pharma AB operates in the Health & Wellness sector.
When did Promore Pharma AB complete a stock split?▼
Promore Pharma AB has not had any recent stock splits.
Where is Promore Pharma AB headquartered?▼
Promore Pharma AB is headquartered in Solna, Sweden.